京新药业：累计回购6.09亿元

Core Viewpoint - The company plans to repurchase shares through a dedicated securities account, indicating a strategy to enhance shareholder value and confidence in the company's future performance [1] Group 1: Share Repurchase Details - As of October 31, 2025, the company will repurchase a total of 47.2713 million shares, which represents 5.49% of the current total share capital [1] - The maximum purchase price for the shares is set at 14.41 CNY per share, while the minimum purchase price is 11.86 CNY per share [1] - The total amount allocated for the share repurchase is 609 million CNY, excluding transaction fees [1]